
NASDAQHealthcareMedical - Instruments & Supplies
ข้อมูลล่าสุด
US$160.32
+US$3.14 · +2.00%
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
ราคาปิดก่อนหน้า
US$160.32
+US$3.14 · +2.00%
หลังปิดตลาด
US$160.32
US$0.00 · 0.00%
9 ต.ค. 18:32 ET
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
ช่วงราคารายวัน
ปัจจุบัน US$160.32
ช่วง 52 สัปดาห์
ปัจจุบัน US$160.32
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ถือ
มูลค่า
58
มูลค่ายุติธรรม
ความเชื่อมั่น
68
เชิงบวก
ความเสี่ยง
30
ความเสี่ยงปานกลาง
โมเมนตัม
60
เป็นกลาง
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
ช่วงราคารายวัน
ปัจจุบัน US$160.32
ช่วง 52 สัปดาห์
ปัจจุบัน US$160.32
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 2.23B USD | 2.38B USD | 2.26B USD | 2.28B USD | 1.32B USD |
| ต้นทุนสินค้าขาย | 1.41B USD | 1.56B USD | 1.52B USD | 1.58B USD | 824.82M USD |
| กำไรขั้นต้น | 819.66M USD | 824.78M USD | 739.87M USD | 697.76M USD | 491.49M USD |
| การวิจัยและพัฒนา | 87.5M USD | 88.62M USD | 85.34M USD | 92.98M USD | 47.5M USD |
| การขาย ทั่วไป และธุรการ | 625.21M USD | 638.76M USD | 606.69M USD | 608.35M USD | 302.58M USD |
| ค่าใช้จ่ายในการดำเนินงาน | 712.71M USD | 781.82M USD | 717.05M USD | 740.66M USD | 368.25M USD |
| รายได้ดอกเบี้ย | 10.31M USD | 10.79M USD | 7.51M USD | 4.43M USD | 2.84M USD |
| ดอกเบี้ยจ่าย | 105.38M USD | 106.54M USD | 102.73M USD | 70.81M USD | 858K USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 200.74M USD | 219.51M USD | 228.77M USD | 235.15M USD | 89.7M USD |
| รายได้จากการดำเนินงาน | 106.95M USD | 42.96M USD | 22.83M USD | −42.9M USD | 123.25M USD |
| รายได้สุทธิ | 732K USD | −117.69M USD | −29.66M USD | −74.29M USD | 103.14M USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 10 ต.ค. 2569.
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
Vanguard Morningstar Total Stock Market ETFVTI137.34M0.01%2.3T USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM102.45M0.13%78.27B USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB99.52M0.05%185.3B USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR63.16M0.09%68.2B USD0.05%US$234.43+0.22%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV54.84M0.20%26.81B USD0.33%US$37.95-0.39%
Vanguard Extended Market ETFVXF50.25M0.05%95.4B USD0.05%US$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM36.13M0.23%15.84B USD0.03%US$53.45+0.17%
iShares Russell 2000 Value ETFIWN36.1M0.26%13.85B USD0.24%US$210.87-0.04%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
iShares Russell 2000 Value ETFIWNเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน